Article
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer
1 Nov 2007
Abstract excerpt
Vascular endothelial growth factor (VEGF), one of the most potent angiogenic factors, is suggested to play a crucial role in tumor neovascularization and is associated with tumor progression and metastasis in prostate cancer. This study evaluated the significance of the VEGF T-460C polymorphism in the risk and the progression of prostate cancer. In a case-control experiment, 270 patients with prostate cancer and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
